Frontiers in Pharmacology | Pharmacology of Anti-Cancer Drugs

Original Research

Published on 21 Mar 2024

Lycium barbarum polysaccharide reverses drug resistance in oxaliplatin-resistant colon cancer cells by inhibiting PI3K/AKT-dependent phosphomannose isomerase

in Pharmacology of Anti-Cancer Drugs

Lijun Ma
Fangfang Ai
Hongyan Xiao
Fang Wang
Lei Shi
Xuehong Bai
Yongzhao Zhu
Wenping Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1367747

3,657 views
7 citations

Original Research

Published on 21 Mar 2024

Addition of nimotuzumab to concurrent chemoradiotherapy after induction chemotherapy improves outcomes of patients with locally advanced nasopharyngeal carcinoma

in Pharmacology of Anti-Cancer Drugs

Run-Jie Wang
Rui-Quan Ke
Yi-Feng Yu
Guan-Zhong Lu
San-Gang Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1366853

1,662 views
2 citations

Original Research

Published on 21 Mar 2024

Exploring HMMR as a therapeutic frontier in breast cancer treatment, its interaction with various cell cycle genes, and targeting its overexpression through specific inhibitors

in Pharmacology of Anti-Cancer Drugs

Aisha Shabir
Hina Qayoom
Burhan Ul Haq
Adel Abo Mansoor
Adil Abdelrahim
Irshad Ahmad
Abdullah Almilabairy
Fuzail Ahmad
Manzoor Ahmad Mir

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1361424

3,031 views
4 citations

Review

Published on 20 Mar 2024

Antibody-drug conjugates targeting HER2 for the treatment of urothelial carcinoma: potential therapies for HER2-positive urothelial carcinoma

in Pharmacology of Anti-Cancer Drugs

Chia-Hsien Shih
Yu-Hua Lin
Hao-Lun Luo
Wen-Wei Sung

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1326296

4,162 views
9 citations

Original Research

Published on 19 Mar 2024

Identification of TBK1 inhibitors against breast cancer using a computational approach supported by machine learning

in Pharmacology of Anti-Cancer Drugs

Arif Jamal Siddiqui
Arshad Jamal
Mubashir Zafar
Sadaf Jahan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1342392

1,932 views
4 citations

Original Research

Published on 18 Mar 2024

PCC0208057 as a small molecule inhibitor of TRPC6 in the treatment of prostate cancer

in Pharmacology of Anti-Cancer Drugs

Yingjie Wei
Min Li
Yuemiao Hu
Jing Lu
Lin Wang
Qikun Yin
Xuechuan Hong
Jingwei Tian
Hongbo Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1352373

2,281 views
1 citation

Original Research

Published on 13 Mar 2024

Development of a prognostic model based on different disulfidptosis related genes typing for kidney renal clear cell carcinoma

in Pharmacology of Anti-Cancer Drugs

Yuanyuan Feng
Wenkai Wang
Shasha Jiang
Yongming Liu
Yan Wang
Xiangyang Zhan
Huirong Zhu
Guoqing Du

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1343819

2,505 views
2 citations

Original Research

Published on 12 Mar 2024

Berberine-based self-assembly agents with enhanced synergistic antitumor efficacy

in Pharmacology of Anti-Cancer Drugs

Yun Wang
Zhongrui Li
Haili Zhang
Peiye Wu
Yu Zhao
Renshi Li
Chao Han
Lei Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1333087

3,019 views
1 citation

Original Research

Published on 11 Mar 2024

Targeting hexokinase 2 for oral cancer therapy: structure-based design and validation of lead compounds

in Pharmacology of Anti-Cancer Drugs

Purbali Chakraborty
Syeda Lubna
Shouvik Bhuin
Deepika K.
Manab Chakravarty
Trinath Jamma
Perumal Yogeeswari

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1346270

3,733 views
5 citations

Review

Published on 08 Mar 2024

AKR1C3 in carcinomas: from multifaceted roles to therapeutic strategies

in Pharmacology of Anti-Cancer Drugs

Mengnan Li
Limin Zhang
Jiahui Yu
Xiaoxiao Wang
Le Cheng
Zhaowu Ma
Xiaoguang Chen
Lingzhi Wang
Boon Cher Goh

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1378292

5,278 views
7 citations

Review

Published on 08 Mar 2024

Insights into the glioblastoma tumor microenvironment: current and emerging therapeutic approaches

in Pharmacology of Anti-Cancer Drugs

Dev Kumar Tripathy
Lakshmi Priya Panda
Suryanarayan Biswal
Kalpana Barhwal

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1355242

6,745 views
16 citations

Systematic Review

Published on 08 Mar 2024

Current trends and emerging patterns in the application of nanomaterials for ovarian cancer research: a bibliometric analysis

in Pharmacology of Anti-Cancer Drugs

Wenhui Wang
Jie Wei
Dingqing Feng
Bin Ling

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1344855

2,675 views
4 citations

Review

Published on 08 Mar 2024

Natural products reverse cancer multidrug resistance

in Pharmacology of Anti-Cancer Drugs

Jia-Yu Zou
Qi-Lei Chen
Xiao-Ci Luo
Davaadagva Damdinjav
Usama Ramadan Abdelmohsen
Hong-Yan Li
Tungalag Battulga
Hu-Biao Chen
Yu-Qing Wang
Jian-Ye Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1348076

14,430 views
17 citations

Original Research

Published on 07 Mar 2024

Identification and validation of prognostic and immunotherapeutic responses in esophageal squamous carcinoma based on hypoxia phenotype-related genes

in Pharmacology of Anti-Cancer Drugs

Kai Xie
Zhe Chen
Jian Feng
Liangbin Pan
Nan Wang
Jing Luo
Yu Yao
Haitao Ma
Yu Feng
Wei Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1344317

1,964 views
1 citation

Original Research

Published on 07 Mar 2024

Surgery combined with anlotinib for local control of patients with resectable extremity desmoid fibromatosis: a retrospective study

in Pharmacology of Anti-Cancer Drugs

Dechao Yuan
Yong Liu
Xiang Fang
Fan Wu
Senlin Lei
Linqi Tu
Fuguo Kuang
Yawei Gou
Chunfu Gong
Wenli Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1357071

974 views
1 citation

Mini Review

Published on 07 Mar 2024

Article review: Brazilin as potential anticancer agent

in Pharmacology of Anti-Cancer Drugs

Callista Najla Raptania
Syifa Zakia
Alistia Ilmiah Fahira
Riezki Amalia

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1355533

6,833 views
3 citations